REGENERON VENTURES Trademark

Trademark Overview

On Tuesday, February 20, 2024, a trademark application was filed for REGENERON VENTURES with the United States Patent and Trademark Office. The USPTO has given the REGENERON VENTURES trademark a serial number of 98412120. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 22, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENERON VENTURES trademark is filed in the Insurance & Financial Services category with the following description:

Capital investment; Investment management; Equity capital investment; Providing venture capital, development capital, private equity and investment funding; Financial investment in the field of biotechnology startups; Venture capital funding services to emerging and start-up companies; Venture capital financing.
regeneron ventures

General Information

Serial Number98412120
Word MarkREGENERON VENTURES
Filing DateTuesday, February 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements

Goods and ServicesCapital investment; Investment management; Equity capital investment; Providing venture capital, development capital, private equity and investment funding; Financial investment in the field of biotechnology startups; Venture capital funding services to emerging and start-up companies; Venture capital financing.
NOT AVAILABLE"VENTURES"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 20, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024NEW APPLICATION ENTERED
Tuesday, June 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2024ASSIGNED TO EXAMINER
Thursday, September 12, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, September 12, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, September 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

ventures regeneron capital investment venture funding equity emerging services start companies financing